Precision Cancer Therapeutics Market, 2022

    Published: October 25, 2022 | Price: $5,000.00 – $10,000.00

    Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry.  Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually.  The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...
    The 2022 World Market for Vaccines

    Published: September 23, 2022 | Price: $5,000.00 – $10,000.00

     V A C C I N E  M A R K E T  E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion.  That's up from $34.1 billion in 2017, and just $25 billion in 2010.  Infectious diseases are some of the deadliest diseases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in...
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022

    Published: August 2, 2022 | Price: $6,000.00 – $12,000.00

    This report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensive coverage of the biotechnology segment of the global BCMO industry. Sales estimates are provided by segment and region, expressed in current dollars. Estimates are provided for the historic 2016 to 2021 period and forecasts are provided through 2026. Further, this report examines third party manufacturing of potential and commercialized prescription drug...
    The Market for Rx-to-OTC Switches, 8th Edition

    Published: May 5, 2022 | Price: $6,000.00 – $12,000.00

    More than 700 pharmaceutical products have made the switch from Rx to OTC over the past several decades. The U.S. Rx-to-OTC market has grown into a $13.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective...